The Lancet Diabetes and Endocrinology Impact Factor, Quartile, Indexing, Ranking

The Lancet Diabetes and Endocrinology Impact Factor, Indexing, Ranking

The Lancet Diabetes and Endocrinology (LDE) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Elsevier. The Print-ISSN of The Lancet Diabetes and Endocrinology is 2213-8587 and its abbreviation is Lancet Diabetes Endocrinol.

The latest Impact Factor of the The Lancet Diabetes and Endocrinology for 2024-2025 is 44.5.

The Publicaiton fees (APC) is 6,300 USD.


The Lancet Diabetes and Endocrinology Aim and Scope

The Lancet Diabetes & Endocrinology is an independent journal with an international perspective and a strong clinical focus. Each monthly issue features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. We publish papers that reflect the rich variety of ongoing clinical research in these fields, especially in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.


The Lancet Diabetes and Endocrinology Details


Journal title The Lancet Diabetes and Endocrinology (LDE)
Abbreviation Lancet Diabetes Endocrinol
Print ISSN 2213-8587
Online ISSN 2213-8595
Publisher Name Elsevier
Editor-in-chief Marta Koch
Subject Category Medicine
Access type Hybrid
Status 🟢 Active

The Lancet Diabetes and Endocrinology Metrics and Rankings

In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.

Below are the metrics and rankings for the journal The Lancet Diabetes and Endocrinology

Impact Factor 44.5
SJR 8.217
SNIP 9.502
Ranking 108
CiteScore 58.1
H-Index 151
Quartile Q1
The Lancet Diabetes and Endocrinology Impact Factor List

The Lancet Diabetes and Endocrinology Review Time

Journal review time is basically how long it takes for experts to read and decide whether an article is good enough to be published in a journal.

Review Time 10 weeks

The Lancet Diabetes and Endocrinology Abstracting and Indexing

Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars

Abstracting and Indexing

The Lancet Diabetes and Endocrinology Submission

If you would like to submit a manuscript or visit the journal's website, please click on the link below.

Journal Submission 🔗 Journal Website

F T L W E